last malignant spinal cord compression (mscc)

Upload: safasayed

Post on 04-Jun-2018

224 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    1/55

    Dr Kamal Hamed

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    2/55

    IntroductionDiagnosis of MSCC is an emergency

    Survival , quality of life are directly related tothe patients pretreatment ambulatory status. Emergency MRI and immediate initiation ofspecific therapy may preserve function.The main causes of delay are failure todiagnose spinal cord compression and failureto investigate and refer urgently (within24 hours)

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    3/55

    60% of the metastases are thoracic.30% are lumbo sacral

    10% are cervical.

    Commonly, breast and lung cancers causethoracic lesions

    Cancer presents as MSCC in 20% of patients.

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    4/55

    Patients with cauda equina syndromeexperience diminished sensation overthe buttocks, posterior-superior

    thighs, and perineal region 20% -80% experience decreased anal sphinctertone.Urinary retention and over flow incontinence arepathognomonic of the syndrome (90%sensitivity; 95% specificity). Absence of a post-void residual virtuallyexcludes it (negative predictive value 99%(

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    5/55

    Anatomy of the spine

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    6/55

    85%From vertebral bodyor pedicle

    10% Throughintervertebral foramina(from paravertebral nodesor mass)

    4% Intramedullary spread

    1%(Low) Direct spread toepidural space

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    7/55

    Different spinalcord levels supplynerves fordifferent regionsof the

    body

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    8/55

    Thoracic spine 60%Lumbosacral spine 30%Cervical spine 10%

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    9/55

    Most commonly seen in Breast Lung Prostate Lymphoma Myeloma

    3-5% of patients with cancer overallApprox 200 cases per annum in North Trent

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    10/55

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    11/55

    Pain 95%

    Weakness 5%Ataxia 1%Sensory loss 1%

    RED FLAGS..

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    12/55

    BACK PAIN is the most common symptom of (MSCC),noted by 83%-95% of patients before its diagnosis. Pain, which can be local, referred, and/or radicular, iscaused by the expanding tumor in the bone, bonecollapse, or nerve damage.Pain is often unilateral with cervical or lumbosacralspine involvement and bilateral with thoracic spinedisease.

    It is usually worse at night and with recumbency,because of lengthening of the spine and distention ofthe spinal epidural venous plexus.Valsalva manouvres and movement also exacerbatethe pain.

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    13/55

    Usually first symptom 80-90% of the time

    Usually precedes other neurologicsymptoms by 7 weeksIncreases in intensity

    Severe local back painAggravated by lying down

    Distension of venous plexus

    Bach, F, Larsen, BH, Rohde, K, et al. Metastatic spinal cord compression.

    Occurrence, symptoms, clinical presentations and prognosis in 398 patients withspinal cord compression. Acta Neurochir (Wien) 1990; 107:37.

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    14/55

    may be mild to begin withlasts for more than 1 - 2 weeks

    Pain may feel like a 'band' around thechest or abdomen ( radicular) Can radiate over the lower back, into thebuttocks or legs

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    15/55

    Weakness: 60-85%Tends to be symmetricalSeverity greatest with thoracic mets

    At or above conus medularisExtensors of the upper extremitiesAbove the thoracic spine

    Weakness from corticospinal dysfunctionAffects flexors in the lower extremities

    Patients may be hyper reflexic below thelesion and have extensor plantars

    Greenberg, HS, Kim, JH, Posner, JB. Epidural spinal cord compressionfrom metastatic tumor: Results with a new treatment protocol. AnnNeurol 1980; 8:361.

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    16/55

    Less common than motor findings

    Still present in majority of cases

    Ascending numbness and parathesiasNumbness or 'pins and needles' in toes &fingers or over the buttocks

    Sensory levelSaddle anaesthesia

    Feeling unsteady on feet, having difficulty withwalking, or legs giving way

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    17/55

    Loss is late finding

    Problems passing urinemay include difficulty controlling bladder functionpassing very little urineor passing none at all

    Constipation or problems controlling bowels

    Autonomic neuropathy presents usually as urinary retentionRarely sole finding

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    18/55

    2-5 monthsmedian

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    19/55

    Common signs of MSCC include radiculopathy,weakness, sensory changes (e.g., paresthesias,loss of sensation).sphincter incontinence, and autonomicdysfunction (e.g., urinary hesitancy, retention).Upper motor neuron weakness is usuallysymmetric.Early lower motor neuron weakness is oftenasymmetric and begins in the distal extremities,as do sensory findings.

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    20/55

    Requires very prompt diagnosis & treatment to tryand prevent catastrophic consequences of paralysis& incontinence

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    21/55

    Delay in diagnosis of MSCC results in loss ofmobility and bladder dysfunction and

    decreased survival.Because therapy is usually well tolerated inambulatory patients (even those with verylimited overall prognoses), the diagnosis ofMSCC should always be considered urgent

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    22/55

    MRI is the gold standard in detectingepidural metastatic disease and frank(SCC) (sensitivity, 93%; specificity, 97%;overall accuracy, 95%).

    Plain spine radiographs have inadequate sensitivityand a false-negative rate of 10% - 17%.No validated predictive models suggest that clinicianscan omit an MRI in a patient with known cancer andback pain.

    Finding unsuspected lesions is not unusual. In 45% ofpatients, MRI findings altered the radiation therapy(RT) field. An MRI of the entire spine is therefore required,including T1-weighted sagittal images with T1- or T2-

    weighted axial images in areas of interest.

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    23/55

    1. MRI scan of the whole spineCan get compression at multiplelevels

    2. Knowledge of cancer type &stage

    3. Knowledge of patient fitness4. Current neurological

    function Have they lost power in theirlegs?Can they walk?Do they need a catheter?

    5. Do they have pain?

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    24/55

    MRI of spinal cord compression in awomen with past history of breast

    cancer

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    25/55

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    26/55

    http://images.google.co.uk/imgres?imgurl=http://www.saspine.org/conditions/disc06.gif&imgrefurl=http://www.saspine.org/conditions/cervical_disc_prolapse.htm&h=324&w=300&sz=37&hl=en&start=11&um=1&tbnid=Pzy5ft80FG5MGM:&tbnh=118&tbnw=109&prev=/images%3Fq%3Dspinal%2Bcord%2Bcompression%26um%3D1%26hl%3Den%26sa%3DN
  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    27/55

    Metastatic cancerHerniated discBenign bony lesionAbscessAlcoholic neuropathyPrimary tumour

    OsteoporosisLow potassium

    Case report3/11 casesconfirmed

    MSCC

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    28/55

    Until spinal stability is confirmed patientsshould be managed on bed rest BUT Whereverpossible keep the patient moving

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    29/55

    Pain control

    Avoidance of complications

    Preserve or improve neurological function

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    30/55

    1. Steroids & gastric protection2. Analgesia

    3. Surgery decompression & stabilisation ofthe spine4. Radiotherapy5. Chemotherapy e.g. lymphoma6. Hormonal manipulation e.g. prostate Ca

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    31/55

    Glucocorticoids reduce injury from traumaticspinal cord injury.

    Dexamethasone decreases vasogenicedema.

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    32/55

    Day Dexamethasonedaily dose

    Administration

    1-3 16mg 16mg OM or 8mg BD(8am & 12noon)

    4-6 8mg 8mg OM7-9 4mg 4mg OM

    10-12 2mg 2mg OM

    13 Discontinue

    While the patient is on steroids commence PPI (e.g. Lansoprazole) forgastric protection. A slower reducing regimen may be required for patients who havereceived previous courses of steroids.

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    33/55

    Debate is ongoing regarding the merits of RT aloneversus surgical therapy followed by RT for selectedpatients with MSCC. Despite finding few papers of high methodological

    quality, a 2005 evidence-based review recommendedradiation for ambulatory patients without spinalinstability, bony compression, or paraplegia onpresentation;

    SURGERY recommended for:

    patients with progressive neurologic deficits,vertebral column instability, radioresistant tumors (lung, colon, renal cell),intractable pain unrelieved by RT

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    34/55

    Unknown primary tumour Relapse post RT Progression while on RT

    Intractable painInstability of spine Patients with a single level of cord

    compression who have not been totallyparaplegic for longer than 48 hoursPrognosis >4 months

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    35/55

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    36/55

    RCT comparing surgery followed by RT vs.RT alone Improvement in surgery + RT

    Days remained ambulatory (126 vs. 35)Percent that regained ambulation after therapy (56% vs.19%)Days remained continent (142 vs. 12)

    Less steroid dose, less narcotics Trend to increase survival

    Patchell, R, Tibbs, PA, Regine, WF, et al. A randomized trial ofdirect decompressive surgical resection in the treatment of spinal

    cord compression caused by metastasis (abstract). proc Am SocClin Oncol 2003; 22:1.

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    37/55

    Relieves compressionRemoves tumourStabilises spine

    But many patients notsuitable

    Unfit Tumour factors

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    38/55

    Approximately 85% of patients with MSCC receive RTalone. The first RT fraction should be delivered within 24hours of a patients first presentation to the radiationoncologist.

    RT is directed at vertebral metastatic sites that are painfulor are associated with significant epidural involvement orthecal sac indentation (i.e., subclinical SCC).Prospective observational studies have shown that 60% -90% of patients achieve pain relief with RT and

    dexamethasone. Of patients who are ambulatory before RT, 60% to 100%maintain the ability to walk.RT ports extend one or two vertebral bodies above andbelow the site of compression

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    39/55

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    40/55

    Urgent access 24/7Dose & schedule

    Depending on neurological deficit, PS, previoustreatment and cancer featuresSingle V fractionated treatment

    SCORAD trial

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    41/55

    Pre operatively noPost operatively routinely

    Definitive all pts unsuitable for surgery

    Unless Total paraplegia (>24hrs) Very poor prognosis

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    42/55

    94% of patients who were ambulatory before surgery plusRT remained ambulatory, whereas only 76% of patientswho received RT alone did so. Thirty-two patients (16 in each treatment group) entered

    the study unable to walk; patients in the surgery groupregained the ability to walk in a significantly greaterproportion than patients in the RT alone group (10 of 16[62%] vs. 3 of 16 [19%]; p 0.01).The need for corticosteroids and opioid analgesics was

    significantly lower in the surgical group, and maintenanceof muscle strength, continence, functional scores, andsurvival (126 vs. 100 days; p 0.033) was significantlygreater in the group receiving surgery before RT.

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    43/55

    Analysis revealed a superior response of thegroup randomly selected to receivedecompressive surgery plus RT. Theposttreatment ambulation rate in the grouprandomly assigned to combination treatmentwas 84%, whereas that in the group randomlyassigned to RT alone was 57% (p 0.001; oddsratio, 6.2 [95% CI, 2.0 to 19.8]),

    patients who underwent surgery plus RTretained ambulation for a significantly longerperiod of time than patients who had RT alone(122 vs. 13 days; p 0.003).

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    44/55

    Can be successful in chemosensitive tumoursHodgkins lymphoma Non-Hodgkins lymphoma NeuroblastomaGerm cellBreast cancer (hormonal manipulation)Prostate cancer (hormonal manipulation)

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    45/55

    Because the epidural space is on the systemicside of the blood-brain barrier, chemotherapyand hormonal therapies have been used in

    individual patients with SCC from Hodgkins andnon- Hodgkins lymphomas, germ cell tumors,breast or prostate carcinomas, orneuroblastomas.In these individual case reports, the MSCCcompletely resolved in five of the seven patientsreported.No large case series or randomized controlledtrials have been conducted.

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    46/55

    Cancer is a hypercoaguable stateHigh burden of tumour in metastatic disease

    Possible value in prophylaxis against venousthromboembolismIf patient not mobile

    subcutaneous low molecular weight heparin +/-compression devices

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    47/55

    FactorsAutonomic dysfunctionLimited mobility

    Opiate analgesic

    Risk of perforation

    Masked by corticosteroids

    Bowel regimen needed

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    48/55

    1. Bed rest V mobilisation Rehabilitation

    Braces & collars2. Psychological issues3. Urinary catheter4. Bowel function5. Nutrition6. Discharge issues

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    49/55

    Median survival with MSCC is 6 months

    Ambulatory patients with radiosensitive

    tumours have the best prognosisLikely to remain mobile

    Sorensen, PS, Borgesen, SE, Rohde, K, et al. Metastatic epiduralspinal cord compression. Results of treatment and survival. Cancer

    1990; 65:1502.

    MSCC is a poor prognostic indicator in cancer patientsNeed better detection rates

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    50/55

    Data from WPH auditNumber of days from admission with

    spinal cord compression to death

    Range = 2 days to 319 days Mean = 58.6 days

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    51/55

    The six factors significantly associated with survivalweretumor type.

    other bone metastases. visceral metastases. interval from tumor diagnosis to MSCC.pre-RT ambulatory status, andtime developing motor deficits before RT.

    The score for each prognostic factor was determinedby dividing the 6-month survival rate (given inpercent) by 10. Total scores represented the sum ofthe six scores obtained for each prognostic factor.

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    52/55

    Selected patients with cancer with a single contiguousarea of compression and a radioresistant tumor maybe candidates for initial surgery followed by radiationtherapy and rehabilitation.

    Patients with multiple sites of compression andtumors other than leukemia, lymphoma, myeloma,breast cancer, or prostate cancer generally have shortsurvivals and may be candidates for shortcourseradiation therapy and hospice care.

    Palliative care can provide expert symptommanagement and can help patients and their familiesbegin to explore and cope with changes in self-image,independence, and roles in the family and communityand, when appropriate, begin advance care planning.

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    53/55

    Diagnosis of MSCC is an emergency.Survival and quality of life are directly relatedto the patients pretreatment ambulatorystatus.Emergency MRI and immediate initiation ofspecific therapy may preserve function.

    Symptomatic therapy includes opioids,corticosteroids, and adjuvants;85% of patients with MSCC receive radiation

    therapy

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    54/55

  • 8/13/2019 Last Malignant Spinal Cord Compression (Mscc)

    55/55